Nanoco — Concentrating on organic business going forward

TMT

Nanoco

Concentrating on organic business going forward

Interim results

Tech hardware and equipment

30 March 2023

Price	20.8p
Market cap	£67m

Net cash (£m) at end January 2023 (excluding lease liabilities and cash from Samsung settlement)		6.0

Shares in issue	322.4m
Free float	84.2%
Code	NANO

Primary exchange	LSE
Secondary exchange	N/A

Share price performance

%	1m	3m	12m
Abs	(14.8)	(51.7)	(27.7)
Rel (local)	(10.9)	(51.8)	(26.1)

52-week high/low

56p

19p

Business description

Nanoco Group is a global leader in developing and manufacturing cadmium-free quantum dots and other nanomaterials, with c 560 patents. Focus applications are advanced electronics, displays, bio-imaging and horticulture.

Next event

FY23 results

October 2023

Analysts

Anne Margaret Crow	+44 (0)20 3077 5700
Dan Ridsdale	+44 (0)20 3077 5700

tech@edisongroup.com

Edison profile page

Nanoco Group is a research client of Edison Investment Research Limited

Nanoco’s H123 revenues benefited from the successful delivery of technical milestones for its European electronics customer, taking it close to full production validation of two different wavelength materials for use in sensing chips. Shortly after the period end, Nanoco signed the final agreements to settle the litigation with Samsung. The settlement frees management to concentrate on getting the company ready for volume production in anticipation of receiving its first production order later in CY23.

Year end	Revenue (£m)	EBITDA (£m)	PBT* (£m)	EPS* (p)	DPS (p)	P/E (x)
07/20	3.9	(2.9)	(4.9)	(1.4)	0.0	N/A
07/21	2.1	(2.8)	(4.7)	(1.3)	0.0	N/A
07/22	2.5	(2.1)	(4.6)	(1.3)	0.0	N/A
07/23e**	6.0	0.5	(0.8)	(0.3)	0.0	N/A

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. **Including £3.0m licence revenues relating to the settlement with Samsung.

Scale-up of sensing material on track

During H123 Nanoco successfully delivered on the technical milestones for the European electronics and Asian chemical customers and supported an increase in demand for volumes of development materials. Revenue jumped by 45% year-on-year to £1.6m, while cost savings from exiting the Manchester facility helped offset inflationary cost increases, so adjusted EBITDA losses were stable at £1.1m. Net cash consumption during H123 was £0.8m, giving a cash balance of £6.0m at the period end. We adjust our estimates to reflect higher headcount costs as Nanoco prepares for volume production in anticipation of receiving its first production order from the European electronics customer later this calendar year.

Litigation against Samsung successfully concluded

Shortly after the H123 period end, Nanoco signed the final agreements to settle the litigation with Samsung on a no fault basis for the alleged infringement of the group’s IP. Samsung agreed to pay Nanoco $150m (£124.3m) in cash in two equal tranches. The first of these has been paid, the second is payable by 3 February 2024 (see our February note for details). After deducting litigation costs, Nanoco will retain c £71.4m net proceeds after costs.

Valuation: Primary value from settlement

Ahead of any of the customer programmes definitely moving to commercial production, much of Nanoco’s value lies in the settlement from Samsung, which has now completed. We will explore the value inherent in the organic business when there is better visibility of production revenues. Meanwhile we note that deployment of its sensing materials by a major mobile phone company in a key handset model could potentially generate c £15–20m annual revenues for Nanoco, while the existing production capacity in Runcorn could generate sensing application revenues of £100m/year working 24/7.

H123 performance

Sensing activity drives H123 performance

Exhibit 1: Comparison of H122, H222 and H123 results

£m	H122	H222	H123
Revenue attributable to ST	0.9	1.2	1.2
Total sales revenue	1.1	1.4	1.6
Cost of sales	(0.1)	(0.3)	(0.3)
Gross profit	1.0	1.1	1.3
Grants	0.2	0.2	0.1
Normalised operating expenses	(2.4)	(2.1)	(2.4)
EBITDA	(1.1)	(0.8)	(1.1)
Share-based payments	(0.4)	(0.3)	(0.5)
Depreciation, amortisation and impairment of intangible items	(0.6)	(1.2)	(0.3)
Exceptional items	0.0	(0.3)	(0.2)
Reported operating loss	(2.1)	(2.6)	(2.1)
Finance costs (net)	(0.2)	(0.2)	(0.2)
Reported loss before tax	(2.3)	(2.9)	(2.3)
R&D tax credits	0.3	0.2	0.3
Reported loss after tax	(2.1)	(2.6)	(2.1)
Adjusted EPS (p)	(0.56)		(0.50)
Basic and diluted EPS (p)	(0.67)		(0.64)

Source: Company data

H123 revenues were higher than H122 and H222 at £1.6m, reflecting intensifying activity on programmes for the European electronics and Asian chemical customers. £1.2m was attributable to services and materials supplied to the European customer, who we have previously inferred is ST Microelectronics, as Nanoco approached full production validation of two nano-materials for the customer. Adjusted EBITDA losses were stable at £1.1m. The cost savings associated with consolidating all activities at the Runcorn site were offset by recent inflation linked cost increases. Exceptional items comprised £0.1m litigation costs and £0.1m employer’s National Insurance on share-based payments.

Net cash (excluding £2.0m IFRS 16 lease liabilities) reduced by £0.8m during the half-year to £6.0m at end January 2023. Key elements of this movement were the EBITDA loss, a £0.9m drop in trade and other receivables following the receipt of a significant payment under the JDA (joint development agreement) with ST, a £0.5m reduction in deferred income following a milestone payment under the JDA and £0.2m (negligible in H122 and H222) investment in tangible fixed assets as the company moved close to production validation of the two nano-materials for sensing and brought the facility for making CFQDs (cadmium-free quantum dots) back into operation. Excluding the cash from the Samsung settlement, management estimates that the company’s cash runway is sufficient to support nanomaterial development and scale-up into CY 2025.

Changes to estimates

We adjusted our FY23 estimates in February to reflect the settlement from Samsung as well as commentary on revenues and operating losses in the trading update. These adjustments included adding £3.0m licence revenues relating to the settlement with Samsung.

We make further adjustments as follows:

■

An additional £0.5m indirect costs during H223 as Nanoco increases headcount in anticipation of commencing production of sensing materials during CY 2024.

■

Removal of £0.5m tax credit payable from the profit and loss account because of the uncertainty regarding the interaction of the profits, potential utilisation of historic losses and the UK Patent Box scheme.

■

Litigation costs, which are treated as an exceptional item and netted against the £70.0m profit on disposal of the IP to give £19.8m exceptional EBIT, of £50.2m vs initial estimate of c £47.0m.

■

£62.1m proceeds from the settlement receivable in FY24 and deferred licence income of £44.8m due after FY23 shown separately on the balance sheet rather than netted together. £2.7m tax asset added to the balance sheet which relates to the Korean withholding tax payable on the second tranche of the settlement when it is received in FY24.

■

Net cash proceeds from the settlement (in FY23) of £4.5m added to the cashflow. This is comprised of £35.2m proceeds from the IP sale and £26.9m deferred licence income netted against £50.2m litigation costs, £2.7m withholding tax payable in South Korea associated with the first tranche of the settlement which was received in FY23 and £4.7m interest payable on loan notes triggered by the settlement. Our previous estimate of the net cash proceeds was £10.8m, with the difference comprising higher than estimated litigation costs, the Korean withholding tax payable on the first tranche of the settlement and £0.3m lower proceeds from disposal of the IP and deferred licence revenue which relates to a change in foreign exchange rates used. £2.7m debit (shown as other in the cashflow) relating to the £2.7m tax asset added to the balance sheet in respect of the Korean withholding tax to be paid in FY24.

Exhibit 2: Revisions to estimates

Y/E July	FY22	FY23
£'m	Actual	New	Old	% change
Revenues	2.5	6.0	6.0	0.0%
Gross profit	2.0	5.4	5.4	0.0%
EBITDA	(2.1)	0.5	1.0	-50.8%
Normalised PBT	(4.6)	(0.8)	(0.3)	-154.2%
Normalised net income	(4.1)	(0.8)	0.2	N/A
Normalised diluted EPS (p)	(1.3)	(0.26)	0.05	N/A
Net debt/(cash)	(2.8)	(5.3)	(14.4)	63.4%

Source: Edison Investment Research

Progress on nanomaterial development and scale-up

Sensing materials

The H123 revenue split (see above) shows that ST is by far the most significant customer. It is likely to remain so in the immediate future because we estimate the fifth work package from ST will generate £1.8m in revenues between May 2022 and May 2023. This work-package covers the final phase of scale-up of a second, longer wavelength material which is close to full production validation and the development of a third material. (Nanoco has already developed and scaled-up production of a shorter wavelength material and is close to full production validation of this material.) The inclusion of development work on a third material emphasises the long-term nature of the relationship with the customer. Nanoco is supplying nanomaterials to ST so its partner can manufacture sensing devices for its end-customers to try out in complete electronic devices. Nanoco has received additional purchase orders for development and validation materials from ST since receiving the fifth work package. Management expects to receive production orders from ST by the end of CY 2023.

Under an agreement signed in May 2020, ST is committed to taking a specified minimum volume of nanomaterials from Nanoco if its enhanced sensing devices gain market traction and commercial volumes are required. These materials would be produced at the existing facility in Runcorn. The potential impact on FY24 revenues will depend on when any potential production ramp-up begins and on the initial use case because ST’s sensing chips may be used in many applications. Deployment by a major mobile phone company in a key handset model could potentially generate c £15–20m annual revenues for Nanoco, while deployment in a more niche application, such as virtual reality (VR) glasses, would generate lower revenues, but is likely to catalyse take-up by other customers. In the longer term, should Nanoco’s material be widely deployed in multiple handset models or other high-volume devices, we note that the existing production capacity in Runcorn could generate sensing application revenues of £100m/year working 24/7.

Nanoco is working with four other customers on materials for use in sensing applications. In September 2022 Nanoco announced that it had received an additional development work package and orders for materials from a major Asian chemical company as well as work for other customers (ie in addition to work for ST). As with ST, Nanoco is supplying nanomaterials to the Asian customer so it can manufacture sensing devices for its end-customers to try out in complete electronic devices.

Display materials

The level of enquiries regarding CFQDs for display applications picked up once it looked likely that Nanoco would win its litigation case against Samsung. For example, a major display OEM is testing samples. Interest has been so high that the company has begun to re-commission its CFQD facility in Runcorn to address demand for samples. In addition, since Nanoco’s rights to its core IP have been fully validated by the legal process, the company has retained an advisor to support an internal team assessing whether any other companies using CFQDs in displays are infringing Nanoco’s IP.

Formal response to shareholder letter

On 27 March, Nanoco issued a formal response to a letter sent to its board by a group of shareholders led by Tariq Hamoodi. In the response, Nanoco's board emphatically rejected the speculative concerns expressed by this group of shareholders about certain actions and activities involving Nanoco. The formal response stated that the directors of Nanoco have no intention of stepping down from the board and are confident that the board's actions and statements over the period of the Samsung litigation were in line with its corporate governance duties, obligations and standards.

Exhibit 3: Financial summary

	£m	2020	2021	2022	2023e
31-July		IFRS	IFRS	IFRS	IFRS
INCOME STATEMENT		restated
Revenue		3.9	2.1	2.5	6.0*
Cost of Sales		(0.3)	(0.2)	(0.4)	(0.6)
Gross Profit		3.5	1.9	2.0	5.4
EBITDA		(2.9)	(2.8)	(2.1)	0.5
Operating profit (before amort. and excepts.)		(4.8)	(4.6)	(4.2)	(0.3)
Amortisation of acquired intangibles		0.0	0.0	0.0	0.0
Exceptionals		(0.7)	0.0	0.0	19.8**
Share-based payments		(0.4)	(0.4)	(0.6)	(0.7)
Reported operating profit		(5.9)	(5.0)	(4.8)	18.8
Net Interest		(0.1)	(0.1)	(0.5)	(0.5)
Exceptionals		0.0	0.0	0.0	(4.7)
Profit Before Tax (norm)		(4.9)	(4.7)	(4.6)	(0.8)
Profit Before Tax (reported)		(6.0)	(5.1)	(5.2)	13.6
Reported tax		0.9	0.7	0.5	0.0
Profit After Tax (norm)		(4.0)	(4.0)	(4.1)	(0.8)
Profit After Tax (reported)		(5.1)	(4.4)	(4.7)	13.6
Minority interests		0.0	0.0	0.0	0.0
Net income (normalised)		(4.0)	(4.0)	(4.1)	(0.8)
Net income (reported)		(5.1)	(4.4)	(4.7)	13.6

Average Number of Shares Outstanding (m)		287	306	308	322
EPS - normalised (p)		(1.39)	(1.30)	(1.32)	(0.26)
EPS - normalised fully diluted (p)		(1.39)	(1.30)	(1.32)	(0.26)
EPS - basic reported (p)		(1.77)	(1.44)	(1.52)	4.21
Dividend per share (p)		0.00	0.00	0.00	0.00

BALANCE SHEET
Fixed Assets		4.6	3.4	1.8	0.6
Intangible Assets		3.7	2.9	1.6	0.6
Tangible Assets		0.9	0.5	0.2	0.0
Deferred income		0.0	0.0	0.0	0.0
Current Assets		7.2	5.8	9.0	75.9
Stocks		0.1	0.1	0.2	0.1
Debtors		1.0	1.2	1.5	1.2
Cash & cash equivalents		5.2	3.8	6.8	9.2
Other (including proceeds from settlement receivable in FY24)		0.9	0.7	0.5	65.3
Current Liabilities		(3.6)	(2.4)	(2.4)	(2.3)
Creditors		(2.3)	(1.6)	(1.5)	(1.5)
Tax and social security		0.0	0.0	0.0	0.0
Short term financial leases		(0.6)	(0.5)	(0.2)	(0.2)
Short term bank debt		0.0	0.0	0.0	0.0
Other (including deferred licence income)		(0.6)	(0.3)	(0.7)	(0.7)
Long Term Liabilities		(1.3)	(3.8)	(4.0)	(48.8)
Long term financial leases		(0.5)	(0.1)	(0.0)	(0.0)
Loan notes		(0.5)	(3.5)	(3.9)	(3.9)
Other (including deferred licence income)		(0.2)	(0.1)	(0.1)	(44.8)
Net Assets		7.0	3.1	4.3	25.4
Minority interests		0.0	0.0	0.0	0.0
Shareholders' equity		7.0	3.1	4.3	25.4

CASH FLOW
Operating Cash Flow		(3.0)	(2.8)	(2.3)	0.5
Working capital		(1.4)	(1.4)	0.1	0.3
Exceptional & other		(0.8)	(0.1)	(0.2)	0.0
Tax		1.1	0.9	0.7	0.0
Net Operating Cash Flow		(4.1)	(3.5)	(1.8)	0.8
Capex		(0.7)	(0.3)	(0.1)	(0.0)
Net proceeds from Samsung settlement		0.0	0.0	0.0	4.5
Net interest		0.0	(0.0)	(0.0)	(0.1)
Equity financing		3.2	0.0	5.4	0.0
Dividends		0.0	0.0	0.0	0.0
Other		(0.8)	2.3	(0.6)	(2.7)
Net Cash Flow		(2.4)	(1.5)	2.9	2.5
Opening net debt/(cash)		(6.6)	(4.7)	(0.3)	(2.8)
FX		0.0	0.0	0.0	0.0
Other non-cash movements		0.6	(3.0)	(0.4)	0.0
Closing net debt/(cash)		(4.7)	(0.3)	(2.8)	(5.3)

Source: Company reports, Edison Investment Research Note: *Including £3.0m licence revenue from Samsung. **£70.0m profit on disposal of IP netted against £50.2m litigation costs.

General disclaimer and copyright

This report has been commissioned by Nanoco Group and prepared and issued by Edison, in consideration of a fee payable by Nanoco Group. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

General disclaimer and copyright

Australia

New Zealand

United Kingdom

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

Equities

Equities by Sector

Sectors

Thematics

Latest

Healthcare-focused trusts: A sector on the mend

MediaWatch – One step forward, two steps back

ConsumerWatch – Don’t look down

Audiovisual

Latest

Recce Pharmaceuticals – executive interview

VEON – executive interview with CFO Joop Brakenhoff

VEON – executive interview with CEO Kaan Terzioğlu

About Edison

About Edison

Careers

Nanoco Group (LSE: NANO)

Nanoco — Concentrating on organic business going forward

TMT

TMT

Latest

Games Workshop Group — A notable acceleration in Q225

Altron — Further margin expansion in H125

Sayona Mining — Catching up with majors

ProCredit Holding — Management expects ROE of c 10% in FY24

Avon Technologies — Record order book driving confident outlook

More on Nanoco Group

Nanoco Group — Board states case for voting against resolutions

Nanoco Group — European partnership not moving forward

Nanoco — Visibility pushed back

Nanoco Group — Sensing the opportunity

Latest from the TMT sector

Altron — Further margin expansion in H125

AUSTRIACARD — Solid Q324 supports FY24 outlook

Nanoco Group — Board states case for voting against resolutions

Dentsu Group — Still fighting market headwinds

Greggs — Profits on the go

Subscribe to Edison